Call for Abstract

4th International conference & Exhibition on Neurology and Therapeutics, will be organized around the theme “Novel Therapies in Neurosciences and Neurological Disorders”

Neuro-2015 is comprised of 11 tracks and 65 sessions designed to offer comprehensive sessions that address current issues in Neuro-2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Neuropathic Pain syndromes
  • Track 1-2Auto immune neuro pathic pain
  • Track 1-3Diagnosis of neuropathic pain
  • Track 1-4Triggers of Migrane
  • Track 1-5pathophysiology of Migrane
  • Track 2-1Neuropsychiatric disturbances
  • Track 2-2Brain cell death
  • Track 2-3Psychiatric disorders
  • Track 2-4Childhood and adolescent psychiatry
  • Track 2-5Neuro Cognitive Disorders
  • Track 2-6Addiction disorders
  • Track 3-1Autism and Pediatric Psychology
  • Track 3-2Neurodevelopmental disorder
  • Track 3-3Epilepsy in children
  • Track 3-4Brain abscesses and rehabehabilitation
  • Track 3-5Neurological rehabilitation program
  • Track 4-1Neuroimmunology
  • Track 4-2 Neuro-immune Interaction
  • Track 4-3Autoimmune Neuropathies
  • Track 4-4 Neuroimmunological Infectious Diseases
  • Track 4-5Blood Brain Barrier and Diseases
  • Track 4-6Neurovirology
  • Track 4-7Neuroimmunogenetics
  • Track 4-8Neuro-immune pathology
  • Track 4-9Neuroinflammation
  • Track 4-10Psychoneuroimmunology
  • Track 5-1Causes and prevention of Alzhiemers
  • Track 5-2Alzheimers disease diagnosis and symptoms
  • Track 5-3Alzheimers disease pathophysiology and disease mechanisms
  • Track 5-4Care Practice and Awarness
  • Track 5-5Therapeutic targets and mechanisms for treatment
  • Track 6-1Amyotrophic lateral sclerosis
  • Track 6-2Hyperkinetic Movement Disorders
  • Track 6-3Parkinsons Disease
  • Track 6-4Pathophysiology and Neuro pharmacology
  • Track 6-5Vasculogenesis and Angiogenesis
  • Track 6-6Navigating Life with Parkinsons
  • Track 6-7Diagnostic Approaches for Parkinsons Disease
  • Track 6-8Therapeutics for Parkinson’s disease
  • Track 7-1Plastic Neurosurgery
  • Track 7-2Brain metastasis
  • Track 7-3Spinal-Cord Tumors
  • Track 7-4Advances in Neurosurgery for Brain Tumors
  • Track 7-5Neurogenetics of Human diseases
  • Track 7-6Genetic Neuroscience
  • Track 8-1Anti-anxiety drugs and Anti-depressants
  • Track 8-2Drug discovery challenges
  • Track 8-3Advancements in the treatment of Neurological disorders
  • Track 8-4Neuroimmuno pharmacology
  • Track 8-5Neurochemical Interactions
  • Track 9-1Neurogenesis and Repair
  • Track 9-2Neural engineering and therapeutics
  • Track 9-3Recent drug development and Diagnosis
  • Track 9-4Clinical Case Reports
  • Track 9-5Cell and gene based therepeutic approach
  • Track 10-1Huntingtons disease
  • Track 10-2Stroke risk factors and their Impact
  • Track 10-3Genetic mutation and neural disorder
  • Track 10-4Hemorrhagic Strokes
  • Track 10-5Brain tumour or Metastasis
  • Track 10-6Acute Stroke Management
  • Track 10-7Treatment for Stroke
  • Track 11-1Market Value and Growth of Drugs
  • Track 11-2Current economic cost of clinical research and drug development
  • Track 11-3Industrial advancements in biopharmaceutical research